ALDH9A1 Up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with ALDH9A1 Up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with ALDH9A1 Up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with ALDH9A1 Up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with ALDH9A1 Up.

Results found

Linked to

 

Label

Description

 

Gene

ENSG00000125686 - mediator complex subunit 1

Gene

ENSG00000105538 - Ras interacting protein 1

Gene

ENSG00000126777 - kinectin 1

Gene

ENSG00000111641 - NOP2 nucleolar protein

Gene

ENSG00000162736 - nicastrin

Gene

ENSG00000159202 - ubiquitin conjugating enzyme E2 Z

Gene

ENSG00000165300 - SLIT and NTRK like family member 5

Gene

ENSG00000090060 - poly(A) polymerase alpha

Gene

ENSG00000105576 - transportin 2

Gene

ENSG00000184838 - proline rich 16

  • Gene

    ENSG00000125686 - mediator complex subunit 1


  • Gene

    ENSG00000105538 - Ras interacting protein 1


  • Gene

    ENSG00000126777 - kinectin 1


  • Gene

    ENSG00000111641 - NOP2 nucleolar protein


  • Gene

    ENSG00000162736 - nicastrin


  • Gene

    ENSG00000159202 - ubiquitin conjugating enzyme E2 Z


  • Gene

    ENSG00000165300 - SLIT and NTRK like family member 5


  • Gene

    ENSG00000090060 - poly(A) polymerase alpha


  • Gene

    ENSG00000105576 - transportin 2


  • Gene

    ENSG00000184838 - proline rich 16

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.